<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00192803</url>
  </required_header>
  <id_info>
    <org_study_id>ACE2.CTIL</org_study_id>
    <nct_id>NCT00192803</nct_id>
  </id_info>
  <brief_title>Non-Insulin Dependent Diabetes Mellitus (NIDDM) and Angiotensin Converting Enzyme 2 (ACE2): Diabetic Patients Treated With Antihypertensive Drugs</brief_title>
  <official_title>ACE/ACE2 Ratio in Diabetic Patients Treated With Antihypertensive Drugs</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rambam Health Care Campus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rambam Health Care Campus</source>
  <brief_summary>
    <textblock>
      This feasibility study is designed to examine modulation of the relative activities of ACE
      and ACE2 in diabetic patients following treatment with the angiotensin type 1 receptor (AT1R)
      antagonist, Candesartan.

      This study will provide a closer insight to the possible involvement of the renin-angiotensin
      system (RAS)-related enzymatic components in development or attenuation of vascular
      pathogenesis.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Educational/Counseling/Training</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>ACE and ACE2 activities in monocytes</measure>
  </primary_outcome>
  <enrollment>20</enrollment>
  <condition>NIDDM</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>candesartan</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Signed informed consent

          -  Non-smokers

          -  Type II DM diagnosed patients

          -  Blood pressure &lt; 135/90

          -  Serum HbA1C &gt; 7%

          -  Serum creatinine &lt; 1mg%

          -  Urine microalbumin &lt; 300 mg/day

          -  Body mass index (BMI) &lt; 35 kg/m2

        Exclusion Criteria:

          -  Insulin-dependent diabetic patients

          -  Patient with persistent microalbuminuria

          -  Patient with history of severe hypertension

          -  Congestive heart failure

          -  Patient receiving renin-angiotensin-aldosterone system (RAAS)-related
             anti-hypertensive medications.

          -  Patient with major hepatic disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shlomo Keidar, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rambam Health Care Campus</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Shlomo Keidar, MD</last_name>
    <phone>97248542518</phone>
    <email>skeidar@rambam.health.gov.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Internal Ward &quot;A&quot;, Rambam Medical Center</name>
      <address>
        <city>Haifa</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ayelet Raz, MD</last_name>
      <phone>972-4-8543072</phone>
    </contact>
    <investigator>
      <last_name>Ayelet Raz, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>September 2005</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 14, 2005</study_first_submitted>
  <study_first_submitted_qc>September 14, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 19, 2005</study_first_posted>
  <last_update_submitted>February 22, 2006</last_update_submitted>
  <last_update_submitted_qc>February 22, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 23, 2006</last_update_posted>
  <keyword>niddm</keyword>
  <keyword>ace2</keyword>
  <keyword>NIDDM patients</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Candesartan</mesh_term>
    <mesh_term>Antihypertensive Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

